http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103896856-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_702110b5c1a76f70dc9b4b944051ca3c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
filingDate 2013-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03b5850c1be5cf55aa2ac67876dee240
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc488086dbc2806d1dd1870e8025d310
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_540bc74ddd84b5bde0f3f808eade6041
publicationDate 2014-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103896856-A
titleOfInvention A multi-substituted monocyclic pyrimidine JNK kinase inhibitor and its preparation method and use
abstract The present invention provides a compound represented by formula (I) or a pharmaceutically acceptable salt, solvate, enantiomer or racemic mixture thereof, wherein M is selected from substituted or unsubstituted aryl, heteroaryl group or a heterocyclic group containing one or more N atoms or sulfur atoms or oxygen atoms or a heterocyclic group containing two heteroatoms in N, O and S; R is selected from H, F, Cl, Br , linear, branched or cyclic C 1 -C 4 alkyl, C 1 -C 4 alkoxy; R 2 selected from H, F, Cl, Br, linear, branched or cyclic C 1 -C 4 alkyl, C 1 -C 4 alkoxy; R 3 is selected from H, F, Cl, Br, linear, branched or cyclic C 1 -C 4 alkyl; R 4 is selected from H, F, Cl, Br, linear, branched or cyclic C 1 -C 4 alkyl; R 5 is selected from H, F, Cl, Br, linear, branched or cyclic C 1 -C 4 alkyl, C 1 -C 4 alkoxy.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11021468-B2
priorityDate 2012-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005047268-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011146287-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11158073-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006034473-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0247690-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009145814-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452580039
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430462419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430701105
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466349667
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421189233
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114488347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466593603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53417518
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114488305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78426215

Total number of triples: 35.